Advisor Group, Inc. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 47 filers reported holding ONCOCYTE CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q4 2019$1,000
-75.0%
262
-82.5%
0.00%
Q3 2019$4,0000.0%1,4970.0%0.00%
Q2 2019$4,000
+300.0%
1,497
+606.1%
0.00%
Q1 2019$1,000212
+1666.7%
0.00%
Q4 2018$0120.0%0.00%
Q3 2018$0120.0%0.00%
Q2 2018$0120.0%0.00%
Q1 2018$0
-100.0%
12
-89.3%
0.00%
Q4 2017$1,0000.0%1120.0%0.00%
Q3 2017$1,0000.0%112
+9.8%
0.00%
Q2 2017$1,0001020.00%
Other shareholders
ONCOCYTE CORP shareholders Q4 2017
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 2,982,557$5,697,0006.44%
BROADWOOD CAPITAL INC 14,716,204$28,108,0002.20%
PURA VIDA INVESTMENTS, LLC 5,983,724$11,429,0001.10%
Mesirow Financial Investment Management, Inc. 99,282$190,0000.90%
P.A.W. CAPITAL CORP 200,000$382,0000.43%
Penbrook Management LLC 215,625$412,0000.40%
EAM Investors, LLC 241,769$462,0000.10%
Private Wealth Partners, LLC 150,000$287,0000.04%
Phoenix Holdings Ltd. 292,275$597,0000.02%
ETF MANAGERS GROUP, LLC 145,650$470,0000.02%
View complete list of ONCOCYTE CORP shareholders